Cargando…

Challenges and opportunities for oral pre-exposure prophylaxis in the prevention of HIV infection: where are we in Europe?

Following US Food and Drugs Administration approval in July 2012 of daily oral tenofovir and emtricitabine for pre-exposure prophylaxis (PrEP) to prevent HIV infection in high-risk individuals in the USA, there has been much controversy about the implementation of this PrEP regimen in other countrie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Molina, Jean-Michel, Pintado, Claire, Gatey, Caroline, Ponscarme, Diane, Charbonneau, Pierre, Loze, Benedicte, Rozenbaum, Willy, Delaugerre, Constance
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751938/ https://www.ncbi.nlm.nih.gov/pubmed/23972284 http://dx.doi.org/10.1186/1741-7015-11-186

Ejemplares similares

Sensitivity of Five Rapid HIV Tests on Oral Fluid or Finger-Stick Whole Blood: A Real-Time Comparison in a Healthcare Setting
por: Pavie, Juliette, et al.
Publicado: (2010)

Acute Hepatitis B Infection After a Switch to Long-Acting Cabotegravir and Rilpivirine
por: Pintado, Claire, et al.
Publicado: (2020)

Effect of On-Demand Oral Pre-exposure Prophylaxis With Tenofovir/Emtricitabine on Herpes Simplex Virus-1/2 Incidence Among Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Trial
por: Chaix, Marie-Laure, et al.
Publicado: (2018)

The air of Europe: where are we going?
por: Annesi-Maesano, Isabella
Publicado: (2017)

Efficacy and safety of rilpivirine-based regimens in treatment-experienced HIV-1 infected patients: a prospective cohort study
por: Gazaignes, Sandrine, et al.
Publicado: (2014)

Emerging evidence from a systematic review of safety of pre‐exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading?
por: Joseph Davey, Dvora L, et al.
Publicado: (2020)

Heart failure and telemedicine: where are we and where are we going? Opportunities and critical issues
por: Calò, Leonardo, et al.
Publicado: (2023)

2.G. Workshop: The development of HTA collaboration in Europe: where we are and where we are going
Publicado: (2022)

Lung cancer screening in Europe: where are we in 2021?
por: van Meerbeeck, Jan P., et al.
Publicado: (2021)

Novel radionuclides for use in Nuclear Medicine in Europe: where do we stand and where do we go?
por: Radzina, Maija, et al.
Publicado: (2023)

Iodine prophylaxis in pregnant women in Poland - where we are? (update 2015)
por: Zygmunt, Arkadiusz, et al.
Publicado: (2015)

Where do we stand with antithrombotic prophylaxis in patients with COVID-19?
por: Ciavarella, Alessandro, et al.
Publicado: (2020)

No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
por: Molina, J.M., et al.
Publicado: (2020)

Prevention and control of malaria and sleeping sickness in Africa: Where are we and where are we going?
por: Corbel, Vincent, et al.
Publicado: (2011)

Inflammatory Markers During Early Treatment of Seroconverters in a Randomized Placebo-Controlled Trial of PrEP (ANRS-IPERGAY)
por: Chawki, Sylvain, et al.
Publicado: (2021)

Opportunities and Challenges of Generic Pre-Exposure Prophylaxis Drugs for HIV
por: Ballreich, Jeromie, et al.
Publicado: (2022)

Antibiotic Prophylaxis for Children with Primary Vesicoureteral Reflux: Where Do We Stand Today?
por: Costers, Michiel, et al.
Publicado: (2008)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Pre-hospital clinical practice guidelines – Where are we now?
por: McCaul, Michael, et al.
Publicado: (2016)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

TSACO’s Third Anniversary: where we were, where we are, and where we’re going
por: Fabian, Timothy
Publicado: (2019)

The Clusmy Child: Where Are We and Where Are We Going?
por: Hadders-Algra, Mijna, et al.
Publicado: (2003)

European HEPnet: where we are and where we are going
por: Carpenter, B E, et al.
Publicado: (1990)

Iron health: where are we and where are we going?
por: Gotardo, Glória Ines Beal
Publicado: (2011)

Animal Sentience: Where are We and Where are We Heading?
por: Proctor, Helen
Publicado: (2012)

Hip Arthroscopy: Where We Are, and Where We Are Going
por: Park, Myung Sik, et al.
Publicado: (2015)

Bioactive Glasses: Where Are We and Where Are We Going?
por: Baino, Francesco, et al.
Publicado: (2018)

Diabetic cardiomyopathy: where we are and where we are going
por: Lee, Wang-Soo, et al.
Publicado: (2017)

Obstetric ultrasound: where are we and where are we going?
por: Abramowicz, Jacques S
Publicado: (2021)

Hidradenitis Suppurativa: Where We Are and Where We Are Going
por: Scala, Emanuele, et al.
Publicado: (2021)

COVID-19: Where We Are, Where We Need to Be
por: Bender Ignacio, Rachel A., et al.
Publicado: (2022)

Where We Are and Where We Are Going in Nut Research
por: Salas-Salvadó, Jordi, et al.
Publicado: (2023)

COVID-19: Where We Are and Where We Are Going
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Telemedicine in ophthalmology - where are we and where are we going?
por: Pîrvulescu, Ruxandra
Publicado: (2023)

Research Integrity: Where We Are and Where We Are Heading
por: Zhaksylyk, Alikhan, et al.
Publicado: (2023)

Where are we coming from? What are we? Where are we going?
por: Ellis, John R.
Publicado: (1995)

The living universe: where are we? who are we? where are we going?
por: Elgin, Duane, et al.
Publicado: (2009)

Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities
por: Kim, Susan C, et al.
Publicado: (2010)

Chikungunya Beyond the Tropics: Where and When Do We Expect Disease Transmission in Europe?
por: Tjaden, Nils Benjamin, et al.
Publicado: (2021)

Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?
por: Aapro, Matti, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_bv2c0knnpc9vdubsun99u5pkvv